Ownership history in RENAISSANCE TECHNOLOGIES LLC · 15 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in CARDIFF ONCOLOGY INC (CRDF). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 101,800 | -27,890 | -21.5% | 0.00% | $210K | $2.06 |
| 2025 Q2 | REDUCED | 129,690 | -353,400 | -73.2% | 0.00% | $409K | $3.15 |
| 2024 Q4 | REDUCED | 483,090 | -119,294 | -19.8% | 0.00% | $2.1M | $4.34 |
| 2024 Q3 | ADDED | 602,384 | +444,894 | +282.5% | 0.00% | $1.6M | $2.67 |
| 2024 Q2 | ADDED | 157,490 | +71,390 | +82.9% | 0.00% | $350K | $2.22 |
| 2024 Q1 | REDUCED | 86,100 | -30,300 | -26.0% | 0.00% | $460K | $5.34 |
| 2023 Q4 | REDUCED | 116,400 | -37,600 | -24.4% | 0.00% | $172K | $1.48 |
| 2023 Q3 | REDUCED | 154,000 | -157,290 | -50.5% | 0.00% | $214K | $1.39 |
| 2023 Q2 | REDUCED | 311,290 | -20,018 | -6.0% | 0.00% | $458K | $1.47 |
| 2023 Q1 | REDUCED | 331,308 | -159,682 | -32.5% | 0.00% | $547K | $1.65 |
As of 2025 Q4 — sorted by position size